Sciclone Pharmaceuticals, Inc. (SCLn) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts SCLn Hot Sheet
Price: $11.15 --0%
Financial Fact:
Interest and investment income: 270K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Interest and investment income: 270K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Sciclone Pharmaceuticals, Inc. (NASDAQ: SCLn) reported Q1 EPS of $0.15, $0.01 better than the analyst estimate of $0.14. Revenue for the quarter came in at $39.2 million versus the consensus estimate of $37.08 million.
For earnings history and earnings-related data on Sciclone Pharmaceuticals, Inc. (SCLn) click here.
For earnings history and earnings-related data on Sciclone Pharmaceuticals, Inc. (SCLn) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is the global equity rally broadening? UBS weighs in
- Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
- Piper Sandler Reiterates Overweight Rating on Patterson-UTI Energy (PTEN)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
